Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Therapix Biosciences has entered into an exclusive agreement with Catalent Pharma Solutions for the formulation, development and clinical manufacturing of THX-TS01.
read more
Therapure Biomanufacturing announced approval for the manufacturing of Insmed’s Arikayce at its Mississauga facility by the FDA.
read more
BIOTECanada announced earlier today Therapure Biopharma Inc. (Therapure) has been named recipient of a Gold Leaf Award recognizing an outstanding early stage health company. Therapure is being recognized for the potential of their highly innovative ...
read more
Thermo Fisher Scientific has announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif.
read more
Wednesday, September 08, 2021
Thermo Fisher Scientific Inc., the world leader in serving science, announced a $192.5 million contract award from the U.S. Department of Defense (DoD) to ensure reliable domestic production of pipette tips, which are used within research and ...
read more
Wednesday, August 30, 2017
Thermo Fisher Scientific has completed its acquisition of Patheon for approximately $7.2 billion.
read more
Tuesday, February 15, 2022
Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. ...
read more
Thermo Fisher Scientific Inc., has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
read more
Wednesday, February 09, 2022
Thermo Fisher Scientific has announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company. Through this partnership, the PPD clinical research business of Thermo Fisher has collaborated with Medidata to develop PPD TrueCast, ...
read more
Friday, February 02, 2018
Senior executives in manufacturing operations within large global corporations have selected the Thermo Scientific InSight wireless cold storage monitoring solution as the winner of the 2017 Manufacturing Leaders' Innovation Award.
read more
Thermo Fisher Scientific has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline.
read more
Thermo Fisher Scientific Inc. announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a provider of specialty diagnostics, from a shareholder group led by European private equity firm Nordic ...
read more
Thermo Fisher Scientific is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
read more
Friday, November 08, 2019
Thermo Fisher Scientific is investing nearly $24 million in its Inchinnan, Scotland, site.
read more
The company is now supporting more than 200 of these projects globally.
read more